Prevalence of SARS-CoV-2 IgG Antibodies in Patients with Cystic Fibrosis at the Minnesota Cystic Fibrosis Center in the First 6 Months of Known Virus in the State and In Follow-Up (6 Months and 1 Year)
- Resource Type
- Source
- TP91. TP091 EPIDEMIOLOGY AND TRANSLATIONAL ADVANCES IN SARS-COV-2.
- Subject
- Language